Vertex: High Growth For Years Ahead

Michele Pagliaro profile picture
Michele Pagliaro
452 Followers

Summary

  • Vertex is the market leader company for Cystic Fibrosis disease.
  • The company reports unexpected sales and earnings growth in recent quarter, Q3.
  • Strong financial position could lead the company into high-level future growth.
  • Vertex can reach an annualized return of 18.6% in the next year.
  • As a growth company and related to the high potential return on the share price, Vertex is a Buy.

Caucasian Scientists use microscopes to research the covid-19 virus vaccine in a medical laboratory

Godji10

Cystic fibrosis (CF) is a progressive genetic disorder that often causes persistent lung infections that eventually cause respiratory depression. More than 83,000 people worldwide suffer from cystic fibrosis, and about 1,000 new diagnoses are made each year.

In

Vertex strategy

Vertex Q3

revenue growth

Author Graphics + Vertex QR

vertex growth CF

Vertex JP Conference

Vertex Operating Income

Author Graphics + Vertex QR

Vertex Cash

Author Graphics + Vertex QR

pipeline

Vertex Q3

pipeline

Vertex JP Conference

SA Vertex valuation

Seeking Alpha

graham formula

Author Valuation Model

graphs valuation model

Author Valuation Model

profile and rating

SA peer comparison

peer comparison

SA Quant Factor Grades

This article was written by

Michele Pagliaro profile picture
452 Followers
Long-time investor. Analyst of growth and value companies. The goal is to create high long-term capital growth.

Disclosure: I/we have a beneficial long position in the shares of VRTX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.